The Efficacy of the Systemic Immune-Inflammation Index and Prognosis Nutritional Index for the Diagnosis of Venous Thromboembolism in Gastrointestinal Cancers

References

• Mahajan A, Brunson A, Eldredge J, et al. Incidence and outcomes associated with 6841 isolated distal deep vein thromboses in patients with 13 common cancers. Thromb Haemost. 2022;17. doi:10.1055/a-1742-0177
   Web of Science ®Google Scholar
• Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5(3):632–634. doi:10.1111/j.1538-7836.2007.02374.x
   PubMed Web of Science ®Google Scholar
• Mahajan A, Brunson A, White R, et al. The epidemiology of cancer-associated venous thromboembolism: an update. Semin Thromb Hemost. 2019;45(4):321–325. doi:10.1055/s-0039-1688494
   PubMed Web of Science ®Google Scholar
• Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–4907. doi:10.1182/blood-2007-10-116327
   PubMed Web of Science ®Google Scholar
• Pabinger I, van Es N, Heinze G, et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol. 2018;5(7):e289–e298. doi:10.1016/S2352-3026(18)30063-2
   PubMed Web of Science ®Google Scholar
• Gerotziafas GT, Mahé I, Lefkou E, et al. Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer. Thromb Res. 2020;191(Suppl 1):S50–S57. doi:10.1016/S0049-3848(20)30397-2
   PubMedGoogle Scholar
• Xiong W, Zhao Y, Du H, et al. Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung cancer. Thromb J. 2021;19(1):95. doi:10.1186/s12959-021-00339-x
   PubMed Web of Science ®Google Scholar
• Blom JW, Vanderschoot JP, Oostindiër MJ, et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006;4(3):529–535. doi:10.1111/j.1538-7836.2006.01804.x
   PubMed Web of Science ®Google Scholar
• Hanna N, Brogly SB, Wei XS, et al. Incidence and risk factors of venous thromboembolism following hepatectomy for colorectal metastases: a population-based retrospective cohort study. World J Surg. 2022;46(1):180–188. doi:10.1007/s00268-021-06316-9
   PubMed Web of Science ®Google Scholar
• Go SI, Lee A, Lee US, et al. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer. Lung Cancer. 2014;84(1):79–85. doi:10.1016/j.lungcan.2014.01.014
   PubMed Web of Science ®Google Scholar
• Yang W, Liu Y. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients. Thromb Res. 2015;136(2):212–215. doi:10.1016/j.thromres.2014.11.025
   PubMed Web of Science ®Google Scholar
• Tian T, Lu J, Zhao W, et al. Associations of systemic inflammation markers with identification of pulmonary nodule and incident lung cancer in Chinese population. Cancer Med. 2022;11(12):2482–2491. doi:10.1002/cam4.4606
   PubMed Web of Science ®Google Scholar
• Kubota K, Ito R, Narita N, et al. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment. BMC Cancer. 2022;22(1):368. doi:10.1186/s12885-022-09439-x
   PubMed Web of Science ®Google Scholar
• Karsy M, Azab MA, Harper J, et al. Evaluation of a D-Dimer protocol for detection of venous thromboembolism. World Neurosurg. 2020;133:e774–e783. doi:10.1016/j.wneu.2019.09.160
   PubMed Web of Science ®Google Scholar
• Pang M, Zhao F, Yu P, et al. The significance of coagulation and fibrinolysis-related parameters in predicting postoperative venous thrombosis in patients with breast cancer. Gland Surg. 2021;10(4):1439–1446. doi:10.21037/gs-21-117
   PubMed Web of Science ®Google Scholar
• Xue J, Ma D, Jiang J, et al. Diagnostic and prognostic value of immune/inflammation biomarkers for venous thromboembolism: is it reliable for clinical practice? J Inflamm Res. 2021;14:5059–5077. doi:10.2147/JIR.S327014
   PubMed Web of Science ®Google Scholar
• Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Neutrophil counts, neutrophil-to-lymphocyte ratio, and Systemic Inflammatory Response Index (SIRI) predict mortality after off-pump coronary artery bypass surgery. Cells. 2022;11(7):1124. doi:10.3390/cells11071124
   PubMed Web of Science ®Google Scholar
• Pinato D, North B, Sharma R, Novel A. Externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the Prognostic Nutritional Index (Pni). Br J Cancer. 2012;106(8):1439–1445. doi:10.1038/bjc.2012.92
   PubMed Web of Science ®Google Scholar
• Guo W, Cai S, Zhang F, et al. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer. Thorac Cancer. 2019;10(4):761–768. doi:10.1111/1759-7714.12995
   PubMed Web of Science ®Google Scholar
• Zhang X, Ding R, Li H, et al. An association between inflammation and cerebral venous thrombosis: a retrospective study. J Stroke Cerebrovasc Dis. 2021;30(11):106084. doi:10.1016/j.jstrokecerebrovasdis.2021.106084
   PubMed Web of Science ®Google Scholar
• Xing Y, Tian Z, Jiang Y, et al. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis. Ann Med. 2022;54(1):302–309. doi:10.1080/07853890.2022.2028893
   PubMed Web of Science ®Google Scholar
• Peng J, Wang H, Zhang L, et al. Construction and efficiency analysis of prediction model for venous thromboembolism risk in the elderly after Hip fracture. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(2):142–148. doi:10.11817/j.issn.1672-7347.2021.190722
   PubMedGoogle Scholar
• Iguchi T, Sugimachi K, Mano Y, et al. The preoperative prognostic nutritional index predicts the development of deep venous thrombosis after pancreatic surgery. Anticancer Res. 2020;40(4):2297–2301. doi:10.21873/anticanres.14195
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Keskin M, Keskin T, et al. A novel independent survival predictor in pulmonary embolism: prognostic nutritional index. Clin Appl Thromb Hemost. 2018;24(4):633–639. doi:10.1177/1076029617703482
   PubMed Web of Science ®Google Scholar
• Oe S, Yamato Y, Hasegawa T, et al. Association between a prognostic nutritional index less than 50 and the risk of medical complications after adult spinal deformity surgery. J Neurosurg Spine;2020. 1–6. doi:10.3171/2020.1.SPINE191410
   PubMed Web of Science ®Google Scholar
• Öcal L, Keskin M, Cerşit S, et al. Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2022;33(4):251–260. doi:10.1097/MCA.0000000000001117
   PubMed Web of Science ®Google Scholar
• Li S, Liu K, Gao Y, et al. Prognostic value of systemic immune-inflammation index in acute/subacute patients with cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020;5(4):368–373. doi:10.1136/svn-2020-000362
   PubMedGoogle Scholar
• Karahan SZ, Gazioglu S, Dilaver I, et al. The role of thrombo-inflammatory biomarkers in the prognosis of cerebral venous sinus thrombosis. Curr Neurovasc Res. 2021;18(2):237–243. doi:10.2174/1567202618666210607151518
   PubMed Web of Science ®Google Scholar
• Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of thrombosis. Arterioscler Thromb Vasc Biol. 2018;38(4):709–725. doi:10.1161/ATVBAHA.117.309846
   PubMed Web of Science ®Google Scholar
• Semeraro F, Ammollo CT, Semeraro N, et al. Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins. Haematologica. 2009;94(6):819–826. doi:10.3324/haematol.2008.000042
   PubMed Web of Science ®Google Scholar
• Preston RJS, O’Sullivan JM, O’Donnell JS. Advances in understanding the molecular mechanisms of venous thrombosis. Br J Haematol. 2019;186(1):13–23. doi:10.1111/bjh.15869
   PubMed Web of Science ®Google Scholar
• Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13–S33. doi:10.1160/THS10-11-0720
   PubMed Web of Science ®Google Scholar
• Basili S, Carnevale R, Nocella C, et al. Serum albumin is inversely associated with portal vein thrombosis in cirrhosis. Hepatol Commun. 2019;3(4):504–512. doi:10.1002/hep4.1317
   PubMed Web of Science ®Google Scholar
• Vara D, Mailer RK, Tarafdar A, et al. NADPH oxidases are required for full platelet activation in vitro and thrombosis in vivo but dispensable for plasma coagulation and hemostasis. Arterioscler Thromb Vasc Biol. 2021;41(2):683–697. doi:10.1161/ATVBAHA.120.315565
   PubMed Web of Science ®Google Scholar
• Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34–45. doi:10.1038/nri3345
   PubMed Web of Science ®Google Scholar
• Luther N, Shahneh F, Brähler M, et al. Innate effector-memory T-cell activation regulates post-thrombotic vein wall inflammation and thrombus resolution. Circ Res. 2016;119:1286–1295. doi:10.1161/CIRCRESAHA.116.309301
   PubMed Web of Science ®Google Scholar
• Spirk D, Sebastian T, Beer JH, et al. Role of age, sex, and specific provoking factors on the distal versus proximal presentation of first symptomatic deep vein thrombosis: analysis of the Swiss Venous ThromboEmbolism Registry (SWIVTER). Intern Emerg Med. 2022;17(3):799–803. doi:10.1007/s11739-021-02878-7
   PubMed Web of Science ®Google Scholar
• Mulder FI, Horváth-Puhó E, van Es N, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959–1969. doi:10.1182/blood.2020007338
   PubMed Web of Science ®Google Scholar
• Ratib S, Walker AJ, Card TR, et al. Risk of venous thromboembolism in hospitalised cancer patients in England-a cohort study. J Hematol Oncol. 2016;9(1):60. doi:10.1186/s13045-016-0291-0
   PubMed Web of Science ®Google Scholar
• Wada T, Fujiwara H, Morita S, et al. Incidence of and risk factors for preoperative deep venous thrombosis in patients undergoing gastric cancer surgery. Gastric Cancer. 2017;20(5):872–877. doi:10.1007/s10120-017-0690-0
   PubMed Web of Science ®Google Scholar
• Daguenet E, Maison M, Tinquaut F, et al. Venous thromboembolism and radiation therapy: the final radiation-induced thrombosis study analysis. Cancer Med. 2022;11(8):1753–1762. doi:10.1002/cam4.4559
   PubMed Web of Science ®Google Scholar
• Grover SP, Hisada YM, Kasthuri RS, et al. Cancer therapy-associated thrombosis. Arterioscler Thromb Vasc Biol. 2021;41(4):1291–1305. doi:10.1161/ATVBAHA.120.314378
   PubMed Web of Science ®Google Scholar
• Oikawa M, Yaegashi D, Yokokawa T, et al. D-Dimer is a predictive factor of cancer therapeutics-related cardiac dysfunction in patients treated with cardiotoxic chemotherapy. Front Cardiovasc Med. 2022;8:807754. doi:10.3389/fcvm.2021.807754
   PubMed Web of Science ®Google Scholar
• Wang P, Zhao H, Zhao Q, et al. Risk factors and clinical significance of D-Dimer in the development of postoperative venous thrombosis in patients with lung tumor. Cancer Manag Res. 2020;12:5169–5179. doi:10.2147/CMAR.S256484
   PubMed Web of Science ®Google Scholar